Kylie Rock

Dr. Kylie Rock

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 March 2018 in Current Environmental Health Reports
Verified
Journal Article
Closed access
PDF file
KRKylie Rock
Kylie Rock
HPHeather Patisaul
Heather Patisaul

1 January 2020 in Advanced Drug Delivery Reviews
Verified
Journal Article
Closed access
NANavein Arumugasaamy
Navein Arumugasaamy
KRKylie Rock
Kylie Rock
CKChe-Ying Kuo
Che-Ying Kuo
TBTracy L. Bale
Tracy L. Bale
JFJohn P. Fisher
John P. Fisher

2 August 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
KRKylie Rock
Kylie Rock
APAllison L. Phillips
Allison L. Phillips
BHBrian Horman
Brian Horman
SASheryl E. Arambula
Sheryl E. Arambula
MRMeghan Rebuli
Meghan Rebuli
HPHeather Patisaul
Heather Patisaul
Firemaster® 550 (FM 550) is a commercial flame retardant mixture of brominated and organophosphate compounds applied to polyurethane foam used in furniture and baby products. Due to widespread human exposure, and structural similarities with known endocrine disruptors, concerns have been raised regarding possible toxicity. We previously reported evidence of sex specific behavioral effects in rats resulting from developmental exposure. The present study expands upon this prior finding by testing for a greater range of behavioral effects, and measuring the accumulation of FM 550 compounds in placental tissue. Wistar rat dams were orally exposed to FM 550 during gestation (0, 300 or 1000 µg/day; GD 9 – 18) for placental measurements or perinatally (0, 100, 300 or 1000 µg/day; GD 9 – PND 21) to assess activity and anxiety-like behaviors. Placental accumulation was dose dependent, and in some cases sex specific, with the brominated components reaching the highest levels. Behavioral changes were predominantly associated with a loss or reversal of sex differences in activity and anxiety-like behaviors. These findings demonstrate that environmental chemicals may sex-dependently accumulate in the placenta. That sex-biased exposure might translate to sex-specific adverse outcomes such as behavioral deficits is a possibility that merits further investigation.

1 July 2020 in Toxicological Sciences
Verified
Journal Article
Open access
PDF file
KRKylie Rock
Kylie Rock
GAGenevieve St Armour
Genevieve St Armour
BHBrian Horman
Brian Horman
APAllison Phillips
Allison Phillips
MRMatthew Ruis
Matthew Ruis
HPHeather Patisaul
Heather Patisaul
There is a growing need to understand the potential neurotoxicity of organophosphate flame retardants (OPFRs) and plasticizers because use and, consequently, human exposure, is rapidly expanding. We have previously shown in rats that developmental exposure to the commercial flame retardant mixture Firemaster 550 (FM 550), which contains OPFRs, results in sex-specific behavioral effects, and identified the placenta as a potential target of toxicity. The placenta is a critical coordinator of fetal growth and neurodevelopment, and a source of neurotransmitters for the developing brain. We have shown in rats and humans that flame retardants accumulate in placental tissue, and induce functional changes, including altered neurotransmitter production. Here, we sought to establish if OPFRs (triphenyl phosphate and a mixture of isopropylated triarylphosphate isomers) alter placental function and fetal forebrain development, with disruption of tryptophan metabolism as a primary pathway of interest. Wistar rat dams were orally exposed to OPFRs (0, 500, 1000, or 2000 μg/day) or a serotonin (5-HT) agonist 5-methoxytryptamine for 14 days during gestation and placenta and fetal forebrain tissues collected for analysis by transcriptomics and metabolomics. Relative abundance of genes responsible for the transport and synthesis of placental 5-HT were disrupted, and multiple neuroactive metabolites in the 5-HT and kynurenine metabolic pathways were upregulated. In addition, 5-HTergic projections were significantly longer in the fetal forebrains of exposed males. These findings suggest that OPFRs have the potential to impact the 5-HTergic system in the fetal forebrain by disrupting placental tryptophan metabolism.

1 November 2015 in Aquatic Toxicology
Verified
Journal Article
Closed access
LMLaura J. Macaulay
Laura J. Macaulay
ACAlbert Chen
Albert Chen
KRKylie Rock
Kylie Rock
LDLaura V. Dishaw
Laura V. Dishaw
WDWu Dong
Wu Dong
HSHeather M. Stapleton
Heather M. Stapleton

30 June 2016 in Toxicological Sciences
Verified
Journal Article
Open access
PDF file
APAllison L. Phillips
Allison L. Phillips
ACAlbert Chen
Albert Chen
KRKylie Rock
Kylie Rock
BHBrian Horman
Brian Horman
HPHeather B. Patisaul
Heather B. Patisaul
HSHeather M. Stapleton
Heather M. Stapleton
Firemaster® 550 (FM 550) is a commercial mixture of organophosphate and brominated flame retardants currently in use as a replacement for pentaBDE. Its organophosphate components include triphenyl phosphate (TPHP) and a suite of isopropylated triarylphosphate isomers (ITPs); its brominated components include 2-ethylhexyl-2,3,4,5-tetrabromobenzoate (EH-TBB) and bis (2-ethylhexyl)-2,3,4,5-tetrabromophthalate (BEH-TEBP). Taken together, these chemicals have been shown to be endocrine disrupting and potentially toxic, and human exposure to them is widespread. In this study, maternal transfer of FM 550 components, and in some cases their metabolites, was investigated in dosed Wistar rats. Gestational and lactational transfer were examined separately, with dams orally exposed to 300 or 1000 µg of FM 550 for ten consecutive days during gestation (GD 9-18) or lactation (PND 3-12). Levels of parent compounds were measured in fetus and whole pup tissue homogenates, and in dam and pup serum, and several metabolites were measured in dam and pup urine. EH-TBB body burdens resulting from lactational transfer were approximately 200-300-fold higher than those resulting from placental transfer, while low levels of BEH-TEBP were transferred during both lactation and gestation. TPHP and ITPs were rapidly metabolized by the dams and were not detected in whole tissue homogenates. However, diphenyl phosphate (DPHP) and mono-isopropylphenyl phenyl phosphate (ip-PPP) were detected in urine from the dosed animals. This study is the first to confirm ip-PPP as a urinary metabolite of ITPs and establish a pharmacokinetic profile of FM 550 in a mammalian model.